Combination therapy with colestipol and psyllium mucilloid in patients with hyperlipidemia

Annals of Internal Medicine

Volumn 123, Issue 7, 1995, Pages 493-499

  Spence, J David ^a   Huff, Murray W ^b   Heidenheim, Paul ^c   Viswanatha, Anne ^d   Munoz, Claudio ^a   Lindsay, Robert ^c   Wolfe, Bernard ^c   Mills, Donald ^c  

^a Stroke Prevention and Atherosclerosis Research Centre   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

^d Victoria Hospital ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLESTIPOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISPAGULA; PSYLLIUM HYDROCOLLOID;

ABDOMINAL CRAMP; ADULT; AGED; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029156642     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-123-7-199510010-00003     Document Type: Article

References (25)

1. The Lipid Research Clinics Coronary Primary Prevention Trial results: I. Reduction in incidence of coronary heart disease. JAMA. 1984;251: 351-64.
2. Alberts AW. Discovery, biochemistry and biology of lovastatin. Am J Cardiol. 1988;62:10J-15J.
3. Witztum JL, Simmons D, Steinberg D, Beltz WF, Weinreb R, Young SG, et al. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride. Circulation. 1989;79:16-28.
4. Anderson JW, Zettwoch N, Feldman T, Tietyen-Clark J, Oeltgen P, Bishop CW. Cholesterol-lowering effects of Psyllium hydrophillic mucilloid for hypercholesterolemic men. Arch Intern Med. 1988;148: 292-6.
5. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. Arch Intern Med. 1988;148:36-69.
6. Guyatt GH, Bombardier C, Tugwell PX. Measuring disease-specific quality of life in clinical trials. Can Med Assoc J. 1986;134:889-95.
7. Jackson DJ. The Basic Personality Inventory. Port Huron, MI: Research Psychologists Pr; 1976.
8. Carmines EG, Zeller RA. Reliability and validity assessment. Beverly Hills, CA: Sage; 1979.
9. Norusis MJ. SPSSPC+ Advanced Statistics V2.0. Chicago:SPSS; 1988.
10. Huff MW, Telford DE, Woodcroft K, Strong WL. Mevinolin and cholestyramine inhibit the direct synthesis of low density lipoprotein apolipoprotein B in miniature pigs. J Lipid Res. 1985;26:1175-86.
11. Huff MW, Telford DE. Characterization and metabolic fate of two very-low-density lipoprotein subfractions separated by heparin-sepharose chromatography. Biochim Biophys Acta. 1984;796:251-61.
12. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 1982;28:1378-88.
13. Castelli WP, Abbott RD, McNamara PM. Summary estimates of cholesterol used to predict coronary artery disease. Circulation. 1983;67: 730-4.
14. Suhonen K, Kantola I, Bjorkslen F. Anaphylactic shock due to ingestion of psyllium laxative. Allergy. 1983;38:363-5.
15. Superko HR, Greenland P, Manchester RA, Andreadis NA, Schectman G, West NH, et al. Effectiveness of low-dose colestipol therapy in patients with moderate hypercholesterolemia. Am J Cardiol. 1992; 70:135-40.
16. Anderson JW, Riddell-Mason S, Gustafson NJ, Smith SF, Mackey M. Cholesterol-lowering effects of psyllium-enriched cereal as an adjunct to a prudent diet in the treatment of mild to moderate hypercholesterolemia. Am J Clin Nutr. 1992;56:93-8.
17. Bell LP, Hectorne K, Reynolds H, Balm TK, Hunninghake DB. Cholesterol-lowering effects of psyllium hydrophilic mucilloid. Adjunct therapy to a prudent diet for patients with mild to moderate hypercholesterolemia. JAMA. 1989;261:3419-23.
18. Levin EG, Miller VT, Muesing RA, Stoy DB, Balm TK, LaRosa JC. Comparison of psyllium hydrophilic mucilloid and cellulose as adjuncts to a prudent diet in the treatment of mild to moderate hypercholesterolemia. Arch Intern Med. 1990;150:1822-7.
19. Sprecher DL, Harris BV, Goldberg AC, Anderson EC, Bayuk LM, Russell BS, et al. Efficacy of psyllium in reducing serum cholesterol levels in hypercholesterolemic patients on high- or low-fat diets. Ann Intern Med. 1993;119(7 Pt 1):545-54.
20. Hunninghake DB, Stein EA, Dujovne CA, Harris WS, Feldman EB, Miller VT, et al. The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia. N Engl J Med. 1993;328:1213-9.
21. Jenkins DJ, Wolever TM, Rao AV, Hegele RA, Mitchell SJ, Ransom TP, et al. Effect on blood lipids of very high intakes of fiber in diets low in saturated fat and cholesterol. N Engl J Med. 1993;329:21-6.
22. Margetts BM, Beilin LF, Vandongen R, Armstrong BK. A randomized controlled trial of the effect of dietary fibre on blood pressure. Clin Sci. 1987;72:343-50.
23. Yeo WW, Ramsay LE. Non-pharmacological treatment of hypertension. In: Robertson JI, ed. Clinical Hypertension. New York: Elsevier; 1992:709-46.
24. Aro A, Uusitupa M, Voutilainen E, Hersio K, Korhonen T, Siitonen O. Improved diabetic control and hypocholesterolaemic effect induced by long-term dietary supplementation with guar gum in type 2 (insulin-independent) diabetes. Diabetologia. 1981;21:29-33.
25. Schrott HG, Stein EA, Dujovne CA, Davidson MH, Goris GB, Oliphant TH, et al. Enhanced low-density lipoprotein cholesterol reduction and cost-effectiveness by low-dose colestipol plus lovastatin combination therapy. Am J Cardiol. 1995;75:34-9.